CCR4-dependent regulatory T cell function in inflammatory bowel disease

Journal of Experimental Medicine

Volumn 204, Issue 6, 2007, Pages 1327-1334

  Yuan, Qian ^a   Bromley, Shannon K ^a   Means, Terry K ^a   Jones, Krister J ^a   Hayashi, Fumitaka ^a   Bhan, Atul K ^a   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE COURSE; IN VITRO STUDY; IN VIVO STUDY; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; INFLAMMATORY BOWEL DISEASES; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CCR4; T-LYMPHOCYTES, REGULATORY;

EID: 34250321683     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20062076     Document Type: Article

References (27)

1. Podolsky, D.K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347:417-429.
2. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589-600.
3. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6:345-352.
4. Luster, A.D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-445.
5. + regulatory T cells. J. Exp. Med. 194:847-853.
6. Curiel, T.J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J.R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10:942-949.
7. + T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201:1037-1044.
8. + regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J. Exp. Med. 203:2451-2460.
9. + regulatory T cells. J. Exp. Med. 204:735-745.
10. Scheerens, H., E. Hessel, R. de Waal-Malefyt, M.W. Leach, and D. Rennick. 2001. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells. Eur. J. Immunol. 31:1465-1474.
11. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061.
12. Lim, H.W., P. Hillsamer, and C.H. Kim. 2004. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J. Clin. Invest. 114:1640-1649.
13. de Jong, Y.P., A.C. Abadia-Molina, A.R. Satoskar, K. Clarke, S.T. Rietdijk, W.A. Faubion, E. Mizoguchi, C.N. Metz, M. Alsahli, T. ten Hove, et al. 2001. Development of chronic colitis is dependent on the cytokine MIF. Nat. Immunol. 2:1061-1066.
14. + regulatory T cells in the steady state. J. Exp. Med. 198:737-746.
15. Szanya, V., J. Ermann, C. Taylor, C. Holness, and C.G. Fathman. 2002. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461-2465.
16. Taylor, P.A., A. Panoskaltsis-Mortari, J.M. Swedin, P.J. Lucas, R.E. Gress, B.L. Levine, C.H. June, J.S. Serody, and B.R. Blazar. 2004. L-Selectin (hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood. 104:3804-3812.
17. Ermann, J., P. Hoffmann, M. Edinger, S. Dutt, F.G. Blankenberg, J.P. Higgins, R.S. Negrin, C.G. Fathman, and S. Strober. 2005. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood. 105:2220-2226.
18. Denning, T.L., G. Kim, and M. Kronenberg. 2005. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J. Immunol. 174:7487-7491.
19. Tang, Q., J.Y. Adams, A.J. Tooley, M. Bi, B.T. Fife, P. Serra, P. Santamaria, R.M. Locksley, M.F. Krummel, and J.A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in non-obese diabetic mice. Nat. Immunol. 7:83-92.
20. + T cells and dendritic cells in vivo. J. Exp. Med. 203:505-511.
21. Mottet, C., H.H. Uhlig, and F. Powrie. 2003. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170:3939-3943.
22. Tang, H.L., and J.G. Cyster. 1999. Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells. Science. 284:819-822.
23. Wu, M., H. Fang, and S.T. Hwang. 2001. Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells. J. Immunol. 167:4791-4795.
24. Chvatchko, Y., A.J. Hoogewerf, A. Meyer, S. Alouani, P. Juillard, R. Buser, F. Conquet, A.E. Proudfoot, T.N. Wells, and C.A. Power. 2000. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J. Exp. Med. 191:1755-1764.
25. Arstila, T., T.P. Arstila, S. Calbo, F. Selz, M. Malassis-Seris, P. Vassalli, P. Kourilsky, and D. Guy-Grand. 2000. Identical T cell clones are located within the mouse gut epithelium and lamina propria and circulate in the thoracic duct lymph. J. Exp. Med. 191:823-834.
26. Fontenot, J.D., M.A. Gavin, A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
27. Kinsella, T.M. and G.P. Nolan. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1405-1413.